milrinone in persistent neonatal pulmonary hypertensio
Phase 3
Recruiting
- Conditions
- neonatal.
- Registration Number
- IRCT20220130053890N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Infants 1 to 28 days with a diagnosis of persistent pulmonary hypertension (diagnosed on Basis of echocardiographic findings) and hospitalization in the NICU.
Indicated for receiving treatment based on the diagnosis of the treating physician.
Existence of informed consent of parents to enter the study.
Exclusion Criteria
Neonates with congenital heart disorders, diaphragmatic hernias, pulmonary abnormalities.
infants are candidates for major surgery to eliminate abnormality.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method